This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American A while ago, I wrote a couple of posts ...
Erratum: Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) The article by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results